FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912942710> ?p ?o ?g. }

• W2912942710 abstract "Peripheral artery disease (PAD), the third leading cause of atherosclerotic vascular morbidity, affects approximately 202 million people worldwide, among whom more than two-thirds reside in low- and middle-income countries (LMIC). For China, the largest developing country, little is known about the epidemiology of PAD. We aimed to estimate the prevalence of PAD and the number of affected people in China, establish the main risk factors for PAD and assess the number of people with PAD at the sub-national level.We searched China National Knowledge Infrastructure (CNKI), Wanfang, Chinese Biomedicine Literature Database (CBM-SinoMed), PubMed, Embase and Medline for population-based studies that have reported the prevalence of PAD in the general Chinese population from 1990 onwards. PAD was defined as an ankle-brachial index (ABI) lower than or equal to 0.90. We used a multilevel mixed-effects logistic regression to generate the gender- and age-specific prevalence of PAD, and a random-effects meta-analysis to pool the odds ratios (ORs) of major risk factors. United Nations population numbers were used to estimate and project the number of affected people from 2000 to 2020. Finally, we used the risk factors-based model to distribute the national number of people with PAD into different settings (urban and rural) and regions (East, Central and West) for the year 2010.Overall, 37 articles met all inclusion criteria and provided prevalence estimates, among which 14 also explored risk factors for PAD. The prevalence of PAD increased gradually by age until mid-60s, after which the increase accelerated. In males, the prevalence of PAD ranged from 2.81% (95% CI = 1.77-4.43) in those aged 25-29 years to 21.95% (95% CI = 15.39-30.31) in those 95-99 years old. In females, the PAD prevalence increased from 3.84% (95% CI = 2.44-5.98) in those aged 25-29 years to 27.95% (95% CI = 20.14-37.37) in those aged 95-99 years. The PAD prevalence was consistently higher in females than in males across all age groups. This difference was most significantly pronounced among the elderly, starting from 60 years. Between 2000 and 2020, the total number of Chinese people with PAD is expected to increase by 40%: from 29.44 million (95% CI = 22.51-38.62) in 2000 to 41.13 million (95% CI = 32.00-52.95) in 2020. Current smoking was the strongest risk factor for PAD, with a meta-odds ratio (OR) of 2.62 (95% CI = 1.44-4.76), followed by hypertension (1.94, 95% CI = 1.48-2.53) and diabetes (1.71, 95% CI = 1.45-2.01). In 2010, 15.18 million (95% CI = 11.74-19.67) people with PAD resided in the East China, 11.08 million (95% CI = 8.61-14.28) in the Central China and 8.65 million (95% CI = 6.71-11.16) in the West China. In addition, 24.20 million (95% CI = 18.82-31.16) people with PAD were living in rural areas, accounting for almost 70% of all PAD cases in China.With rapid ageing in China, PAD has become a serious public health problem. More research and optimal interventions on PAD are required to better identify effective strategies for prevention and treatment of PAD in China." @default.
• W2912942710 created "2019-02-21" @default.
• W2912942710 creator A5004001647 @default.
• W2912942710 creator A5025889107 @default.
• W2912942710 creator A5038431304 @default.
• W2912942710 creator A5057120703 @default.
• W2912942710 creator A5070430303 @default.
• W2912942710 date "2019-03-15" @default.
• W2912942710 modified "2023-10-05" @default.
• W2912942710 title "National and subnational estimation of the prevalence of peripheral artery disease (PAD) in China: a systematic review and meta-analysis" @default.
• W2912942710 cites W1964491153 @default.
• W2912942710 cites W1966148435 @default.
• W2912942710 cites W1971095820 @default.
• W2912942710 cites W1971462837 @default.
• W2912942710 cites W1988593591 @default.
• W2912942710 cites W1990405213 @default.
• W2912942710 cites W2004389985 @default.
• W2912942710 cites W2007954468 @default.
• W2912942710 cites W2011220719 @default.
• W2912942710 cites W2036522489 @default.
• W2912942710 cites W2042071058 @default.
• W2912942710 cites W2053898563 @default.
• W2912942710 cites W2095219849 @default.
• W2912942710 cites W2095690133 @default.
• W2912942710 cites W2099124751 @default.
• W2912942710 cites W2105674008 @default.
• W2912942710 cites W2109266439 @default.
• W2912942710 cites W2110101054 @default.
• W2912942710 cites W2111936593 @default.
• W2912942710 cites W2120827920 @default.
• W2912942710 cites W2130826421 @default.
• W2912942710 cites W2134783879 @default.
• W2912942710 cites W2136823073 @default.
• W2912942710 cites W2138281999 @default.
• W2912942710 cites W2140136269 @default.
• W2912942710 cites W2144985796 @default.
• W2912942710 cites W2148374679 @default.
• W2912942710 cites W2148663700 @default.
• W2912942710 cites W2150130690 @default.
• W2912942710 cites W2154443303 @default.
• W2912942710 cites W2156098321 @default.
• W2912942710 cites W2157569293 @default.
• W2912942710 cites W2162304980 @default.
• W2912942710 cites W2166109718 @default.
• W2912942710 cites W2171923126 @default.
• W2912942710 cites W2204863787 @default.
• W2912942710 cites W246286872 @default.
• W2912942710 cites W2463986804 @default.
• W2912942710 cites W2549031161 @default.
• W2912942710 cites W2552730765 @default.
• W2912942710 cites W2580792129 @default.
• W2912942710 cites W2600421033 @default.
• W2912942710 cites W2600954565 @default.
• W2912942710 cites W4236938366 @default.
• W2912942710 cites W4294215472 @default.
• W2912942710 doi "https://doi.org/10.7189/jogh.09.010601" @default.
• W2912942710 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6377796" @default.
• W2912942710 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30873278" @default.
• W2912942710 hasPublicationYear "2019" @default.
• W2912942710 type Work @default.
• W2912942710 sameAs 2912942710 @default.
• W2912942710 citedByCount "33" @default.
• W2912942710 countsByYear W29129427102019 @default.
• W2912942710 countsByYear W29129427102020 @default.
• W2912942710 countsByYear W29129427102021 @default.
• W2912942710 countsByYear W29129427102022 @default.
• W2912942710 countsByYear W29129427102023 @default.
• W2912942710 crossrefType "journal-article" @default.
• W2912942710 hasAuthorship W2912942710A5004001647 @default.
• W2912942710 hasAuthorship W2912942710A5025889107 @default.
• W2912942710 hasAuthorship W2912942710A5038431304 @default.
• W2912942710 hasAuthorship W2912942710A5057120703 @default.
• W2912942710 hasAuthorship W2912942710A5070430303 @default.
• W2912942710 hasBestOaLocation W29129427101 @default.
• W2912942710 hasConcept C107130276 @default.
• W2912942710 hasConcept C126322002 @default.
• W2912942710 hasConcept C144024400 @default.
• W2912942710 hasConcept C149923435 @default.
• W2912942710 hasConcept C151956035 @default.
• W2912942710 hasConcept C156957248 @default.
• W2912942710 hasConcept C166957645 @default.
• W2912942710 hasConcept C17744445 @default.
• W2912942710 hasConcept C191935318 @default.
• W2912942710 hasConcept C199539241 @default.
• W2912942710 hasConcept C205649164 @default.
• W2912942710 hasConcept C2779473830 @default.
• W2912942710 hasConcept C2908647359 @default.
• W2912942710 hasConcept C71924100 @default.
• W2912942710 hasConcept C95190672 @default.
• W2912942710 hasConcept C99454951 @default.
• W2912942710 hasConceptScore W2912942710C107130276 @default.
• W2912942710 hasConceptScore W2912942710C126322002 @default.
• W2912942710 hasConceptScore W2912942710C144024400 @default.
• W2912942710 hasConceptScore W2912942710C149923435 @default.
• W2912942710 hasConceptScore W2912942710C151956035 @default.
• W2912942710 hasConceptScore W2912942710C156957248 @default.
• W2912942710 hasConceptScore W2912942710C166957645 @default.
• W2912942710 hasConceptScore W2912942710C17744445 @default.
• W2912942710 hasConceptScore W2912942710C191935318 @default.
• W2912942710 hasConceptScore W2912942710C199539241 @default.

• next